Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,138.50    -7.50 (-0.65%)
Bid:
1,143.00
Ask:
1,143.50
Spread: 0.50 (0.044%)
Market Cap: £9.63b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

13 Aug 2025 17:08

RNS Number : 2390V
Smith & Nephew Plc
13 August 2025
 

SMITH & NEPHEW PLC

 

13 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020

 

On 13 August 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.

 

All figures in these columns are stated to 6 decimal places where applicable.

 

 

PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

 

The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of shares were sold to cover taxation obligations arising on the vesting of the awards.

 

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting on 12 August 2025 of Conditional Share awards granted on 11 August 2023 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability

Date of Transaction

2025 - 08 - 12

Place of Transaction

London Stock Exchange (XLON)

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Rohit Kashyap

(President, Advanced Wound Management and Global

PDMR

13.571365

23,201 (of which 5,670 were sold and 17,531 were retained.)

N/A Single Transaction

 

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIRTEIVLIE
Date   Source Headline
26th Aug 20254:25 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20255:20 pmRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSDirector/PDMR Shareholding
19th Aug 20257:00 amRNSTransaction in Own Shares
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20255:08 pmRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20254:30 pmRNSHolding(s) in Company
7th Aug 20253:15 pmRNSHolding(s) in Company
7th Aug 202510:34 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:01 amRNSShare Buyback Programme
5th Aug 20257:00 amRNSHalf-year Report
1st Aug 202510:21 amRNSTotal Voting Rights
21st Jul 202511:51 amRNSNotice of Results
11th Jul 202510:00 amRNSDirector/PDMR Shareholding
1st Jul 20251:30 pmRNSTotal Voting Rights
13th Jun 20257:00 amRNSDirectorate Change
6th Jun 20254:16 pmRNSDirector/PDMR Shareholding
2nd Jun 20252:07 pmRNSTotal Voting Rights
30th May 20251:22 pmRNSDirector/PDMR Shareholding
21st May 20253:00 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSSterling Amount of Dividend
7th May 202511:53 amRNSDirector/PDMR Shareholding
2nd May 202511:30 amRNSDirector/PDMR Shareholding
1st May 202511:27 amRNSTotal Voting Rights
30th Apr 20255:30 pmRNSResult of AGM
30th Apr 20257:00 amRNSSmith+Nephew First Quarter 2025 Trading Update
28th Apr 20251:49 pmRNSHolding(s) in Company
25th Apr 20259:18 amRNSDirectorate Change
22nd Apr 20257:00 amRNSNotice of Results
1st Apr 202512:41 pmRNSTotal Voting Rights
27th Mar 20259:17 amRNSDirector/PDMR Shareholding
27th Mar 20259:12 amRNSDirector/PDMR Shareholding
11th Mar 20253:25 pmRNSDirector/PDMR Shareholding
10th Mar 20252:46 pmRNSAnnual Financial Report
3rd Mar 20252:58 pmRNSTotal Voting Rights
25th Feb 20257:00 amRNSFinal Results
12th Feb 20257:11 amRNSBlock listing Interim Review
6th Feb 20257:00 amRNSNotice of Results
3rd Feb 202510:27 amRNSTotal Voting Rights
14th Jan 20257:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.